Yttrium News and Research

RSS
Yttrium is a metal of the rare earth group of elements. A radioactive form of yttrium may be attached to a monoclonal antibody or other molecule that can locate and bind to cancer cells and be used to diagnose or treat some types of cancer.
Spectrum Pharmaceuticals reports $15.7M revenue from ZEVALIN sales in 2009

Spectrum Pharmaceuticals reports $15.7M revenue from ZEVALIN sales in 2009

Liver cancer: Treatment with intra-arterial yttrium-90 microspheres promising

Liver cancer: Treatment with intra-arterial yttrium-90 microspheres promising

Interventional radiologists to highlight scientific advances, new discoveries at 35th Annual Scientific Meeting

Interventional radiologists to highlight scientific advances, new discoveries at 35th Annual Scientific Meeting

Two U.S. insurers approve coverage of radioembolization for treatment of unresectable liver cancer

Two U.S. insurers approve coverage of radioembolization for treatment of unresectable liver cancer

Zevalin clinical data presented at 2009 ASH meeting

Zevalin clinical data presented at 2009 ASH meeting

Spectrum Pharmaceuticals reports consolidated revenues of $7.1M for the third quarter of 2009

Spectrum Pharmaceuticals reports consolidated revenues of $7.1M for the third quarter of 2009

Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin’s Lymphoma

Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin’s Lymphoma

MIPI to sub-license the Onalta brand 90-Y edotreotide radiotherapeutic

MIPI to sub-license the Onalta brand 90-Y edotreotide radiotherapeutic

Carbon nanotubes may help regrow nerve tissue according to a research study

Carbon nanotubes may help regrow nerve tissue according to a research study

Monoclonal antibody cancer therapy

Monoclonal antibody cancer therapy

Scientists coax bright white light from zinc oxide

Scientists coax bright white light from zinc oxide

FDA accepts Zevalin supplemental biologics license application

FDA accepts Zevalin supplemental biologics license application

New Jefferson trial to test radiation-emitting beads against advanced liver cancer

New Jefferson trial to test radiation-emitting beads against advanced liver cancer

High-tech dental lasers eliminate bacteria in root canals

High-tech dental lasers eliminate bacteria in root canals

Early stage pancreatic cancer expresses antigen targeted by Immunomedics' PAM4 antibody

Early stage pancreatic cancer expresses antigen targeted by Immunomedics' PAM4 antibody

Scientists develop magnetic nanoparticles for medicine

Scientists develop magnetic nanoparticles for medicine

Yttrium-90 to control hepatocarcinoma

Yttrium-90 to control hepatocarcinoma

Radioimmunotherapy streamlines non-Hodgkin's lymphoma treatment

Radioimmunotherapy streamlines non-Hodgkin's lymphoma treatment

Zevalin safe and effective for non-Hogdkin's lymphoma patients

Zevalin safe and effective for non-Hogdkin's lymphoma patients

Nonsurgical microspheres an option for liver cancer patients

Nonsurgical microspheres an option for liver cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.